retatrutide triple agonist glp-1 gip glucagon phase 2 trial obesity Efficacy and safety of retatrutide, a GIP, GLP-1, and receptor agonist, in people with type diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, 3 Trajectory of weight regain after

The profound exhaustion, cognitive impairment often described as "brain fog," and unpredictable crashes can make simply getting through the day feel like running a marathon

Heres where things stand with GLP-1 pills, plus whats coming down the pipeline

FDA Status: Why BPC157 Isnt Approved and What That Means Despite its growing popularity in online forums and biohacking circles, BPC157 is not approved for medical use in humans or animals by the U.S

Zhen Ci Yan Jiu

Glycine supplementation has been explored with tirzepatide ( semaglutide with glycine ) for its potential anti-nausea and metabolic benefits

10.1021/acs.jafc.8b05057 J Agric Food Chem